1.Effects of fluvastatin alone and in combination with gemfibrozil on lipids and glucose tolerance in resistant hyperlipidaemia

Tomlinson, B, Wong,     More...

Tomlinson, B, Wong, SY, Lan, W, Critchley, JAJH, Mak, TWL, Lam, CWK, Woo, KS, Sanderson, JE     Less

ATHEROSCLEROSIS[0021-9150], Published 1997, Volume 134, Issue 1-2, Pages 62-62

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  2.889 

2.Response to bezafibrate in combined hyperlipidaemia

Lan, W, Tomlinson, B     More...

Lan, W, Tomlinson, B, Chau, YM, Say, TK, Lee, KKC, Critchley, JAJH, Mak, TWL, Lam, CWK     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S55-S55

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  2.885 

3.Combination treatment with fluvastatin and gemfibrozil in resistant hyperlipidaemia

Tomlinson, B, Wong,     More...

Tomlinson, B, Wong, SY, Lan, W, Critchley, JAJH, Mak, TWL, Lam, CWK, Woo, KS, Sanderson, JB     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S56-S56

收錄情况： WOS

WOS核心合集引用: 1  2023影響因子:  4.9  发表年影響因子:  2.885 

4.DISTRIBUTIONS OF SERUM LIPOPROTEIN(A), LIPIDS AND APOLIPOPROTEINS AND IDENTIFICATION OF EXTREME VALUES SUGGESTING GENETIC LIPID DISORDERS IN CHINESE UNIVERSITY STUDENTS IN MACAU

Tomlinson, B, Lam, K     More...

Tomlinson, B, Lam, K, Lam, C     Less

ATHEROSCLEROSIS[0021-9150], Published 2023, Volume 379, Pages S53-S53

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  4.9